What this study is
The patient-clinician relationship is fundamental to providing high-quality patient-centered medical care. A therapeutic alliance (TA) is a patient clinician relationship that is characterized by mutual caring, trust, understanding, and respect. A strong TA between oncologists and patients with advanced cancer is associated with several positive health outcomes for patients and caregivers. However, previous work showed a stark disparity in the TA for Latino/a patients with advanced cancer vs. non-Latino/a white patients. The overall objective of this study is to pilot the Heightening Oncologist-Latino/a cancer patient Alliances (HOLA) intervention to assess its feasibility, acceptability, and appropriateness, and the preliminary efficacy of the intervention's impact on the TA between oncologists and their Latino/a patients with advanced cancer. The HOLA intervention will teach oncologists specific evidence based skills and behaviors for promoting a TA with Latino/a advanced cancer patients through the integration of patient-centered communication techniques that are aligned with Latino/a cultural values via commonly encountered clinical scenarios. The investigators will pilot test the HOLA intervention with eight oncologists and 32 of their patients, half (n=16 patients) who are under the care of an oncologist who will be randomized to receive the TA intervention (n=4 oncologists), and half (n=16 patients) who are under the care of an oncologist (n=4 oncologists) who was randomized to usual care. The feasibility, acceptability, and appropriateness of the intervention will be assessed using standard measures. Preliminary efficacy will be determined by comparing the mean TA scores for the oncologists who were randomized to receive the intervention to the mean TA scores for the oncologists who were randomized to usual care.
What's being tested
- HOLA Intervention
Intervention · OTHER
The HOLA intervention is aimed at oncologists and consists of a one hour interactive didactic session and a one-hour small group session. Pre-recorded video vignettes and role playing with a trained moderator will be incorporated both into the interactive group didactic session and the small group session.
Study details
- Official title
- Heightening Oncologist-Latino/a Cancer Patient Alliances (HOLA) Intervention Pilot Study
- Sponsor
- Rutgers, The State University of New Jersey
- Conditions
- Therapeutic Alliances
- Enrolling
- 32 people
- Starts
- 2026-11
- Est. completion
- 2027-01
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 89 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Identifying as ethnically Latino;
- Locally advanced or metastatic cancer (pancreaticobiliary, esophagogastric, hepatocellular carcinoma, lung, or gynecological cancer) AND have experienced disease progression on at least first-line chemotherapy
- Ability to provide informed consent.
You can't join if
- Not fluent in English or Spanish;
- Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of < 6 during screening);
- Too ill or weak to complete the interviews (as judged by interviewer);
- Children and young adults under age 21
- Patients deemed inappropriate for the study by their treating oncologist.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openRutgers New Jersey Medical School
Newark, New Jersey, United States
Study team
Sponsor
Rutgers, The State University of New Jersey
Study ID Pro2025000017
Principal investigator
Ana Tergas, MPH, MD
Rutgers, The State University of New Jersey
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.